Uterine-preserving pelvic organ prolapse surgery using the UPHOLD LITE vaginal support system: The outcomes of 291 patients

This article aims to evaluate the safety and outcome of women with pelvic organ prolapse (POP) treated by a minimally invasive bilateral sacrospinous hysteropexy (UPHOLD LITE Vaginal Support System, Boston Scientific) without concomittent anti-incontinence surgery.This retrospective study was conduc...

Full description

Saved in:
Bibliographic Details
Published in:Medicine (Baltimore) 2019-04, Vol.98 (14), p.e15086-e15086
Main Authors: Chang, Chia-Pei, Hsu, Fang-Kuo, Lai, Man-Jung, Chang, Wen-Hsun, Lee, Na-Rong, Lee, Hui-Ling, Horng, Huann-Cheng, Wang, Peng-Hui
Format: Article
Language:English
Subjects:
Aged
Female
Gynecologic Surgical Procedures - adverse effects
Gynecologic Surgical Procedures - methods
Humans
Lower Urinary Tract Symptoms - etiology
Middle Aged
Observational Study
Organ Sparing Treatments - methods
Pelvic Organ Prolapse - surgery
Postoperative Complications - etiology
Reoperation - statistics & numerical data
Retrospective Studies
Surgical Mesh - adverse effects
Treatment Outcome
Uterus - surgery
Vagina - surgery
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This article aims to evaluate the safety and outcome of women with pelvic organ prolapse (POP) treated by a minimally invasive bilateral sacrospinous hysteropexy (UPHOLD LITE Vaginal Support System, Boston Scientific) without concomittent anti-incontinence surgery.This retrospective study was conducted between 2014 and 2016. Evaluated items included surgical parameter and postoperative outcome.Three hundred thirteen women with POP were eligible and 22 were excluded because of history of either or more following situations, such as hysterectomy, mesh augmentation, previous anti-incontinence procedures, and radical pelvic surgery before. With a median follow-up of 26 months, surgery-related morbidity rate was 23.7% (69/291), including 1 with bladder injury (0.3%), 2 with hematoma (0.7%), 8 with urinary tract infection (2.8%), 48 with voiding dysfunction (16.5%) and 10 with mesh problems (3.4%). Among these morbidities, 12 patients (4.1%) needed surgical intervention, including 6 for mesh problems, 1 for bladder injury, 2 for hematoma, and 3 for anti-incontinence surgery. The difference of pelvic organ prolapse quantification (POP-Q) stage before and after surgery showed a statistical significance (anterior portion from 1.36 ± 2.60 to -2.69 ± 0.26, posterior portion from -1.29 ± 2.08 to -2.46 ± 0.62, and cervix portion from 2.03 ± 4.80 to -6.98 ± 2.26, all P 
ISSN:0025-7974
1536-5964
DOI:10.1097/MD.0000000000015086